MeSH tree: C14.280.647.250
An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource to identify those with a genetic risk for elevated "bad" cholesterol—a major contributor to heart ...
Oct 30, 2025
0
23
Female individuals may experience a three-fold reduction in mortality risk from coronary heart disease when following recommended exercise guidelines, compared to male individuals. These findings, published in Nature Cardiovascular ...
Oct 28, 2025
0
50
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout stenting only if necessary ...
Oct 28, 2025
0
12
A comprehensive study of electronic health records for 57 million people living in England has revealed the evolving burden of cardiovascular diseases before, during and after the COVID-19 pandemic.
Oct 27, 2025
0
18
The strong opioid painkiller tramadol is not significantly effective at easing the chronic pain for which it's widely prescribed, finds a pooled data analysis of the available research, published in BMJ Evidence-Based Medicine.
Oct 7, 2025
0
113
Monash University researchers are using the power of consumer AI to evaluate the safety and repurposing potential of medicines.
Oct 7, 2025
0
21
Patients undergoing coronary angiography often experience anxiety both before and during the procedure, often treated by the administration of anti-anxiety medications. A new analysis being presented at the American College ...
Oct 2, 2025
0
13
British adults eat just 18g of dietary fiber daily, far below the recommended 30g, putting millions at risk of developing heart disease, type 2 diabetes, and colorectal cancer.
Sep 29, 2025
0
12
Consumers read common supplement label phrases as promises of disease prevention or treatment, according to University of Texas Southwestern Medical Center and Duke University Medical Center research.
Researchers led by the National Heart, Lung, and Blood Institute report that menopausal hormone therapy relieved vasomotor symptoms without raising cardiovascular risk in younger women, but increased risk was evident in women ...
